RDGT vs PBH

For growth investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger pick with 1. 1% revenue growth year-over-year, versus -22. 4% for Ridgetech Inc. (RDGT). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 7x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Prestige Consumer Healthcare Inc.

(PBH) delivered a total return of +18. 4%, compared to -100. 0% for Ridgetech Inc. (RDGT). Over 10 years, the gap is even starker: PBH returned -3. 7% versus RDGT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Prestige Consumer Healthcare Inc.

(PBH) is the lower-risk stock at 0. 53β versus Ridgetech Inc. 's 1. 10β — meaning RDGT is approximately 105% more volatile than PBH relative to the S&P 500. On balance sheet safety, Ridgetech Inc. (RDGT) carries a lower debt/equity ratio of 35% versus 57% for Prestige Consumer Healthcare Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Prestige Consumer Healthcare Inc.

(PBH) is pulling ahead at 1. 1% versus -22. 4% for Ridgetech Inc. (RDGT). On earnings-per-share growth, the picture is similar: Ridgetech Inc. grew EPS 162. 8% year-over-year, compared to 2. 9% for Prestige Consumer Healthcare Inc.. Over a 3-year CAGR, PBH leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus 8. 5% for Ridgetech Inc. — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus -0. 9% for RDGT. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53)). Both have compounded well over 10 years (PBH: -3. 7%, RDGT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RDGT is a small-cap quality compounder stock; PBH is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.